Topic: Immunology.
Destination: Projects in the field of immunology related to Deucravacitinib (Sotyktu) which belongs to a class of drugs known as kinase inhibitors may participate in this call. It works by blocking the action of the abnormal protein that signals cells to multiply. Projects on other topics will also be accepted , as long as they are not: pediatric studies, combinations with other disease-modifying therapies, alternative dosing regimens or treatments for Alopecia Areata, vitiligo or Hidradenitis suppurativa.
Budget: Not indicated.
Duration: Not indicated
Omple el següent formulari per rebre més informació:
| Galeta | Durada | Descripció |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |